Pages that link to "Q71673006"
Jump to navigation
Jump to search
The following pages link to Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system (Q71673006):
Displaying 29 items.
- Proglumide as a morphine adjunct in cancer pain management (Q28275789) (← links)
- The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. (Q34581978) (← links)
- Cholecystokinin-octapeptide constricts guinea-pig and human airways (Q35756568) (← links)
- Neuromodulatory Actions of Dopamine and Cholecystokinin in the Ventral Striatum (Q36926721) (← links)
- Neurons with multiple messengers--distribution and possible functional significance (Q39460963) (← links)
- Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology (Q39643228) (← links)
- Morphology and distribution of peptide-containing neurones in the cerebral cortex (Q39750060) (← links)
- Cholecystokinin in the central nervous system: A minireview (Q40092916) (← links)
- Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin (Q41456791) (← links)
- Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics (Q41581740) (← links)
- Release of cholecystokinin from rat midbrain slices and modulatory effect of D2 DA receptor stimulation (Q41905017) (← links)
- A cholecystokinin-like hormone activates a feeding-related neural circuit in lobster (Q43784101) (← links)
- Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance (Q44335778) (← links)
- Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors (Q46501068) (← links)
- Cholecystokinin-octapeptide fragments: Binding to brain cholecystokinin receptors (Q46905979) (← links)
- Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons (Q48121842) (← links)
- Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics (Q48223883) (← links)
- Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function (Q48250949) (← links)
- Enhancement of latent inhibition in the rat by the CCK antagonist proglumide (Q48469842) (← links)
- Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons (Q48668517) (← links)
- Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin (Q48750512) (← links)
- Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors (Q48903261) (← links)
- Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens (Q48932372) (← links)
- Blocking of cholecystokinin octapeptide behavioral effects by proglumide (Q49018675) (← links)
- In vivo release of CCK-8 from the dorsal horn of the rat: Inhibition by DAGOL (Q59616333) (← links)
- Effects of cholecystokinin on morphine-elicited hyperactivity in hamsters (Q67843382) (← links)
- Ontogeny of cholecystokinin-8 and glutamic acid decarboxylase in cerebral neocortex of macaque monkey (Q69962996) (← links)
- Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro (Q70140915) (← links)
- Caerulein may potentiate morphine-induced antinociception by cholecystokinin-A and/or cholecystokinin-B receptor mechanisms (Q73024482) (← links)